Division of Hematology & Oncology
The Hematology/Oncology Division is devoted to state-of-the-art and compassionate treatment in malignant and non-malignant blood disorders, hemostasis and thrombosis, hematopoietic stem cell transplantation and cellular therapeutics, and solid tumor oncology. We are committed to improving care for tomorrow's patients and have robust clinical trials and translational research programs. Our 35 hematologists/oncologists provide care at our outpatient facilities at the Emily Couric Clinical Cancer Center or in our Community Oncology sites in Fishersville, Culpeper, and Charlottesville (Pantops location). We provide comprehensive care in our inpatient Hematology/Oncology and stem cell units and on the hematology and oncology consultation services.
UVA Researchers Awarded $13 Million for National Study to Battle Leukemia
UVA Comprehensive Cancer Center Director Thomas P. Loughran Jr., MD, and Professors of Medicine/ Hematology and Oncology Charles Chalfant, PhD, and David Feith, PhD, have been awarded a new five-year, $13 million National Cancer Institute (NCI) program project grant to lead a multiinstitution, interdisciplinary study seeking new therapies for acute myeloid leukemia (AML).
Learn More-
Comprehensive Cancer Center tapped as ‘Great Oncology Program’Learn MoreBecker’s Hospital Review included UVA Health and UVA Comprehensive Cancer Center on its 2025 list of 100 hospitals and health systems with great oncology programs. “These leading institutions have earned national distinction for advancing cancer care through groundbreaking research, innovative treatments, and transformative clinical trials,” the national health care publication’s editors wrote.
-
Dr. Craig Portell Discusses Blood Cancer Awareness Month with NBC29 Community ConversationWatch VideoSeveral types of blood cancers can present in many ways. Some blood cancers can be associated with environmental exposures; however, those exposures are rare. Symptoms vary between different kinds of blood cancers. There are treatments available, and several blood cancers are even curable.
- Meet Dr. Matthew Reilley and learn about his researchWatch Video
Matthew Reilley, MD, Associate Professor of Medicine, leads clinical trials that pair promising new therapies with cancer patients to improve health outcomes.
- Meet UVA Medical Oncologist, Dr. Ryan GentzlerWatch Video
Dr. Gentzler’s clinical focus is the treatment of patients with lung cancer and other thoracic malignancies. His research is centered around the development of novel therapies for lung cancer. His goal is to contribute meaningful research that leads to improvements in the curability, survival, and quality of life for patients with lung cancer.
- Meet UVA Hematologist/Oncologist, Karen Ballen, MDWatch Video
Dr. Ballen is Division Chief of Hematology and Oncology, Section Head, Hematology and Stem Cell Transplantation, and Medical Director - Stem Cell Transplantation Program. Here research interests are in novel treatments for acute leukemia, stem cell transplantation, cord blood transplantation, haploidentical transplantation, immunotherapy treatment for hematologic malignancies.
- Meet Hematologist Louise Man, MDWatch Video
Dr. Man manages patients with a spectrum of benign hematological conditions. She has a clinical interest in quality improvement and a research interest in disorders of thrombosis and hemostasis.
Inpatient Hematology and Oncology Moonlighting Information
Links to information and required paperwork for individuals who wish to moonlight.